Syk: a novel target for treatment of inflammation in lung disease.

Abstract

Spleen Tyrosine Kinase (Syk) is widely expressed in the immune system and functions in the transmission of inflammatory signals via ITAM-bearing cell surface receptors. The broad expression pattern and importance of Syk in regulating innate immunity and the inflammatory response have led to significant interest from the pharmaceutical industry to developing… (More)

Topics

Cite this paper

@article{Sanderson2009SykAN, title={Syk: a novel target for treatment of inflammation in lung disease.}, author={Michael P. Sanderson and Christine W Lau and Andreas Schnapp and Chung-Wai Chow}, journal={Inflammation & allergy drug targets}, year={2009}, volume={8 2}, pages={87-95} }